Stock VXRT VAXART, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vaxart, Inc.

Equities

VXRT

US92243A2006

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
0.7289 USD -2.68% Intraday chart for Vaxart, Inc. +2.71% +27.25%
03-14 Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-14 Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
AQ
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
AQ
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
AQ
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
AQ
Vaxart Appoints Steven Lo as Chief Executive; Shares Fall
MT
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
AQ
Vaxart, Inc. Announces Chief Executive Officer Changes
CI
Vaxart, Inc. Announces Management Appointments
CI
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
AQ
North American Morning Briefing : Stock Futures -2-
DJ
B. Riley Upgrades Vaxart to Buy From Neutral, Lifts PT to $2 From $1.50
MT
Vaxart Secures $9.3 Million Award for Phase 2b COVID-19 Pill Study
MT
Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
AQ
Vaxart to Raise $10 Million From RA Capital Management; Shares Rise
MT
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
AQ
Vaxart, Inc. Announces Management Change
AQ
Vaxart, Inc. Announces CEO Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VXRT Stock
  4. News Vaxart, Inc.